Localized co-delivery of collagenase and trastuzumab by thermosensitive hydrogels for enhanced antitumor efficacy in human breast xenograft

References

• Beyer I, Li Z, Persson J, et al. (2011). Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumab. Mol Ther 19:479–89.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Y, Shen W, et al. (2016). Controlled release of liraglutide using thermogelling polymers in treatment of diabetes. Sci Rep 6:31593
   PubMed Web of Science ®Google Scholar
• Cho H, Kwon GS. (2014). Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery. J Drug Target 22:669–77.
   PubMed Web of Science ®Google Scholar
• Ci T, Chen L, Yu L, et al. (2014). Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel. Sci Rep 4:5473
   PubMed Web of Science ®Google Scholar
• Desantis CE, Ma J, Goding Sauer A, et al. (2017). Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67:439–48.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Secomb TW. (2017). Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer 17:738–50.
   PubMed Web of Science ®Google Scholar
• Eikenes L, Bruland OS, Brekken C, et al. (2004). Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts. Cancer Res 64:4768–73.
   PubMed Web of Science ®Google Scholar
• Frost GI. (2007). Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration. Expert Opin Drug Deliv 4:427–40.
   PubMed Web of Science ®Google Scholar
• Ghahremankhani AA, Dorkoosh F, Dinarvand R. (2008). PLGA-PEG-PLGA tri-block copolymers as in situ gel-forming peptide delivery system: effect of formulation properties on peptide release. Pharm Dev Technol 13:49–55.
   PubMed Web of Science ®Google Scholar
• Heldin CH, Rubin K, Pietras K, et al. (2004). High interstitial fluid pressure: an obstacle in cancer therapy. Nat Rev Cancer 4:806–13.
   PubMed Web of Science ®Google Scholar
• Hu H, Lin Z, He B, et al. (2015). A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel. J Control Release 220:189–200.
   PubMed Web of Science ®Google Scholar
• Hudis CA. (2007). Trastuzumab-mechanism of action and use in clinical practice. N Engl J Med 357:39–51.
   PubMed Web of Science ®Google Scholar
• Jain RK. (1990). Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res 50:814s–9s.
   PubMed Web of Science ®Google Scholar
• Jain RK, Stylianopoulos T. (2010). Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7:653–64.
   PubMed Web of Science ®Google Scholar
• Kato M, Hattori Y, Kubo M, et al. (2012). Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex. Int J Pharm 423:428–34.
   PubMed Web of Science ®Google Scholar
• Klouda L, Mikos AG. (2008). Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 68:34–45.
   PubMed Web of Science ®Google Scholar
• Lee ALZ, Ng VWL, Gao S, et al. (2014). Injectable hydrogels from triblock copolymers of vitamin E-functionalized polycarbonate and poly(ethylene glycol) for subcutaneous delivery of antibodies for cancer therapy. Adv Funct Mater 24:1538–50.
   Web of Science ®Google Scholar
• Lin Z, Gao W, Hu H, et al. (2014). Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: high drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity. J Control Release 174:161–70.
   PubMed Web of Science ®Google Scholar
• Magzoub M, Jin S, Verkman AS. (2008). Enhanced macromolecule diffusion deep in tumors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin. Faseb J 22:276–84.
   PubMed Web of Science ®Google Scholar
• Marcucci F, Bellone M, Rumio C, et al. (2013). Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells. MAbs 5:34–46.
   PubMed Web of Science ®Google Scholar
• Minchinton AI, Tannock IF. (2006). Drug penetration in solid tumours. Nat Rev Cancer 6:583–92.
   PubMed Web of Science ®Google Scholar
• Moslehi JJ. (2016). Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med 375:1457–67.
   PubMed Web of Science ®Google Scholar
• Netti PA, Berk DA, Swartz MA, et al. (2000). Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 60:2497–503.
   PubMed Web of Science ®Google Scholar
• Provenzano PP, Inman DR, Eliceiri KW, et al. (2008). Collagen density promotes mammary tumor initiation and progression. BMC Med 6:11
   PubMed Web of Science ®Google Scholar
• Shi K, Wang YL, Qu Y, et al. (2016). Synthesis, characterization, and application of reversible PDLLA-PEG-PDLLA copolymer thermogels in vitro and in vivo. Sci Rep 6:19077
   PubMed Web of Science ®Google Scholar
• Shin TH, Sung ES, Kim YJ, et al. (2014). Enhancement of the tumor penetration of monoclonal antibody by fusion of a neuropilin-targeting peptide improves the antitumor efficacy. Mol Cancer Ther 13:651–61.
   PubMed Web of Science ®Google Scholar
• Shpilberg O, Jackisch C. (2013). Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase. Br J Cancer 109:1556–61.
   PubMed Web of Science ®Google Scholar
• Smith PK, Krohn RI, Hermanson GT, et al. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85.
   PubMed Web of Science ®Google Scholar
• Sood N, Bhardwaj A, Mehta S, et al. (2016). Stimuli-responsive hydrogels in drug delivery and tissue engineering. Drug Deliv 23:758–80.
   PubMed Web of Science ®Google Scholar
• Visscher DW. (2011). Genomics, histopathology, and the tumor microenvironment: new relationship or old friends re-discovered? Breast Cancer Res Treat 125:697–8.
   PubMed Web of Science ®Google Scholar
• Vogel CL, Cobleigh MA, Tripathy D, et al. (2002). Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20:719–26.
   PubMed Web of Science ®Google Scholar
• Von Minckwitz G, Procter M, De Azambuja E, et al. (2017). Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer. N Engl J Med 377:122–31.
   PubMed Web of Science ®Google Scholar
• Wolinsky JB, Colson YL, Grinstaff MW. (2012). Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release 159:14–26.
   PubMed Web of Science ®Google Scholar
• Xu K, Lee F, Gao S, et al. (2015). Hyaluronidase-incorporated hyaluronic acid-tyramine hydrogels for the sustained release of trastuzumab. J Control Release 216:47–55.
   PubMed Web of Science ®Google Scholar
• Yu L, Ci T, Zhou S, et al. (2013). The thermogelling PLGA–PEG–PLGA block copolymer as a sustained release matrix of doxorubicin. Biomater Sci 1:411–20.
   PubMed Web of Science ®Google Scholar